Your browser doesn't support javascript.
Neuroscience20 (BRAIN20, SPINE20, and MENTAL20) Health Initiative: A Global Consortium Addressing the Human and Economic Burden of Brain, Spine, and Mental Disorders Through Neurotech Innovations and Policies.
Morris, Kevin; Nami, Mohammad; Bolanos, Joe F; Lobo, Maria A; Sadri-Naini, Melody; Fiallos, John; Sanchez, Gilberto E; Bustos, Teshia; Chintam, Nikita; Amaya, Marco; Strand, Susanne E; Mayuku-Dore, Alero; Sakibova, Indira; Biso, Grace Maria Nicole; DeFilippis, Alejandro; Bravo, Daniela; Tarhan, Nevzat; Claussen, Carsten; Mercado, Alejandro; Braun, Serge; Yuge, Louis; Okabe, Shigeo; Taghizadeh-Hesary, Farhad; Kotliar, Konstantin; Sadowsky, Christina; Chandra, P Sarat; Tripathi, Manjari; Katsaros, Vasileios; Mehling, Brian; Noroozian, Maryam; Abbasioun, Kazem; Amirjamshidi, Abbas; Hossein-Zadeh, Gholam-Ali; Naraghi, Faridedin; Barzegar, Mojtaba; Asadi-Pooya, Ali A; Sahab-Negah, Sajad; Sadeghian, Saeid; Fahnestock, Margaret; Dilbaz, Nesrin; Hussain, Namath; Mari, Zoltan; Thatcher, Robert W; Sipple, Daniel; Sidhu, Kuldip; Chopra, Deepak; Costa, Francesco; Spena, Giannantonio; Berger, Ted; Zelinsky, Deborah.
  • Morris K; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Nami M; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Bolanos JF; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Lobo MA; Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Iran.
  • Sadri-Naini M; Middle East Brain + Initiative, Los Angeles, CA, USA.
  • Fiallos J; Neuroscience Center, Instituto de Investigaciones Científicas Servicios de Alta Tecnología, City of Knowledge, Panama City, Panama.
  • Sanchez GE; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Bustos T; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Chintam N; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Amaya M; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Strand SE; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Mayuku-Dore A; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Sakibova I; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Biso GMN; Brain Mapping Foundation, Los Angeles, CA, USA.
  • DeFilippis A; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Bravo D; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Tarhan N; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Claussen C; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Mercado A; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Braun S; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Yuge L; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Okabe S; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Taghizadeh-Hesary F; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Kotliar K; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Sadowsky C; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Chandra PS; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Tripathi M; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Katsaros V; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Mehling B; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Noroozian M; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Abbasioun K; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Amirjamshidi A; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Hossein-Zadeh GA; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Naraghi F; Brain Mapping Foundation, Los Angeles, CA, USA.
  • Barzegar M; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Asadi-Pooya AA; Middle East Brain + Initiative, Los Angeles, CA, USA.
  • Sahab-Negah S; Department of Psychiatry, Faculty of Medicine, Uskudar University, Istanbul, Turkey.
  • Sadeghian S; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Fahnestock M; Fraunhofer-Institute for Translational Research and Pharmacology, Hamburg, Germany.
  • Dilbaz N; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Hussain N; Department of Neurosurgery, Hospital Military Regional Mendoza, Mendoza, Argentina.
  • Mari Z; AFM-Telethon France, Paris, France.
  • Thatcher RW; Society for Brain Mapping and Therapeutics, Los Angeles, CA, USA.
  • Sipple D; Division of Bio-Environment Adaptation Sciences, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Sidhu K; Cell Therapy Venture Company, Space Bio-Laboratories, Hiroshima, Japan.
  • Chopra D; Brain Medical Science Collaboration Division, RIKEN Center for Brain Science Institution and Department: Cellular Neurobiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Costa F; Social Science Research Institute, Tokai University, Shibuya City, Tokyo, Japan.
  • Spena G; Department of Biomedical Engineering, Aachen University of Applied Sciences, Aachen, Germany.
  • Berger T; International Center for Spinal Cord Injury, Kennedy Krieger Institute-Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Zelinsky D; Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
J Alzheimers Dis ; 83(4): 1563-1601, 2021.
Article in English | MEDLINE | ID: covidwho-1468319
ABSTRACT
Neurological disorders significantly impact the world's economy due to their often chronic and life-threatening nature afflicting individuals which, in turn, creates a global disease burden. The Group of Twenty (G20) member nations, which represent the largest economies globally, should come together to formulate a plan on how to overcome this burden. The Neuroscience-20 (N20) initiative of the Society for Brain Mapping and Therapeutics (SBMT) is at the vanguard of this global collaboration to comprehensively raise awareness about brain, spine, and mental disorders worldwide. This paper aims to provide a comprehensive review of the various brain initiatives worldwide and highlight the need for cooperation and recommend ways to bring down costs associated with the discovery and treatment of neurological disorders. Our systematic search revealed that the cost of neurological and psychiatric disorders to the world economy by 2030 is roughly $16T. The cost to the economy of the United States is $1.5T annually and growing given the impact of COVID-19. We also discovered there is a shortfall of effective collaboration between nations and a lack of resources in developing countries. Current statistical analyses on the cost of neurological disorders to the world economy strongly suggest that there is a great need for investment in neurotechnology and innovation or fast-tracking therapeutics and diagnostics to curb these costs. During the current COVID-19 pandemic, SBMT, through this paper, intends to showcase the importance of worldwide collaborations to reduce the population's economic and health burden, specifically regarding neurological/brain, spine, and mental disorders.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Global Burden of Disease / International Cooperation / Mental Disorders / Nervous System Diseases Type of study: Diagnostic study / Health economic evaluation / Reviews Limits: Humans Language: English Journal: J Alzheimers Dis Journal subject: Geriatrics / Neurology Year: 2021 Document Type: Article Affiliation country: JAD-215190

Full text: Available Collection: International databases Database: MEDLINE Main subject: Global Burden of Disease / International Cooperation / Mental Disorders / Nervous System Diseases Type of study: Diagnostic study / Health economic evaluation / Reviews Limits: Humans Language: English Journal: J Alzheimers Dis Journal subject: Geriatrics / Neurology Year: 2021 Document Type: Article Affiliation country: JAD-215190